688266

Suzhou Zelgen Biopharmaceuticals
688266

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN„31.02B
EV
CN„29.89B
Shares Outstanding
264.71M
Beta
0.32

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN„135.00
P/E 2025E
294.22x
P/Revenue 2025E
36.74x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

gainify
688266

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

688266

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers donafenib tablets; recombinant human thrombin for topincal use; jacktinib tablets; and recombinant human thyroid-stimulati...

Sector

Healthcare

Industry

Biotechnology

CEO

Sheng, Zelin

Employees

910

IPO Date

2020-01-23

Headquarters

No. 209, Chenfeng Road, Kunshan, Jiangsu Province, 215300, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.